Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

Treatment-failure tularemia in children

  • Karli, Arzu (Division of Pediatric Infectious Diseases, Ondokuz Mayis University Faculty of Medicine) ;
  • Sensoy, Gulnar (Division of Pediatric Infectious Diseases, Ondokuz Mayis University Faculty of Medicine) ;
  • Paksu, Sule (Department of Pediatrics, Ondokuz Mayis University Faculty of Medicine) ;
  • Korkmaz, Muhammet Furkan (Department of Pediatrics, Ondokuz Mayis University Faculty of Medicine) ;
  • Ertugrul, Omer (Department of Pediatrics, Ondokuz Mayis University Faculty of Medicine) ;
  • Karli, Rifat (Departments of Otorhinolaryngology, Ondokuz Mayis University Faculty of Medicine)
  • 투고 : 2017.07.11
  • 심사 : 2017.12.15
  • 발행 : 2018.02.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: Tularemia is an infection caused by Francisella tularensis. Its diagnosis and treatment may be difficult in many cases. The aim of this study was to evaluate treatment modalities for pediatric tularemia patients who do not respond to medical treatment. Methods: A single-center, retrospective study was performed. A total of 19 children with oropharyngeal tularemia were included. Results: Before diagnosis, the duration of symptoms in patients was $32.15{\pm}17.8days$. The most common lymph node localization was the cervical chain. All patients received medical treatment (e.g., streptomycin, gentamicin, ciprofloxacin, and doxycycline). Patients who had been given streptomycin, gentamicin, or doxycycline as initial therapy for 10-14 days showed no response to treatment, and recovery was only achieved after administration of oral ciprofloxacin. Response to treatment was delayed in 5 patients who had been given ciprofloxacin as initial therapy. Surgical incision and drainage were performed in 9 patients (47.5%) who were unresponsive to medical treatment and were experiencing abcess formation and suppuration. Five patients (26.3%) underwent total mass excision, and 2 patients (10.5%) underwent fine-needle aspiration to reach a conclusive differential diagnosis and inform treatment. Conclusion: The causes of treatment failure in tularemia include delay in effective treatment and the development of suppurating lymph nodes.

키워드

참고문헌

  1. Lamps LW, Havens JM, Sjostedt A, Page DL, Scott MA. Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America. Mod Pathol 2004;17:489-95. https://doi.org/10.1038/modpathol.3800087
  2. Kilic S, Celebi B, Acar B, Atas M. In vitro susceptibility of isolates of Francisella tularensis from Turkey. Scand J Infect Dis 2013;45:337-41. https://doi.org/10.3109/00365548.2012.751125
  3. Ulu-Kilic A, Gulen G, Sezen F, Kilic S, Sencan I. Tularemia in central Anatolia. Infection 2013;41:391-9. https://doi.org/10.1007/s15010-012-0355-1
  4. Gozel MG, Engin A, Altuntas EE, Salk I, Kaya A, Celik C, et al. Evaluation of clinical and laboratory findings of pediatric and adult patients with oropharyngeal tularemia in Turkey: a combination of surgical drainage and antibiotic therapy increases treatment success. Jpn J Infect Dis 2014;67:295-9. https://doi.org/10.7883/yoken.67.295
  5. Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev 2002;15:631-46. https://doi.org/10.1128/CMR.15.4.631-646.2002
  6. Tarnvik A, Chu MC. New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci 2007;1105:378-404. https://doi.org/10.1196/annals.1409.017
  7. Perez-Castrillon JL, Bachiller-Luque P, Martin-Luquero M, Mena-Martin FJ, Herreros V. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis 2001; 33:573-6. https://doi.org/10.1086/322601
  8. Tezer H, Ozkaya-Parlakay A, Aykan H, Erkocoglu M, Gulhan B, Demir A, et al. Tularemia in children, Turkey, September 2009-November 2012. Emerg Infect Dis 2015;21:1-7.
  9. Kosker M, Sener D, Kilic O, Akil F, Yilmaz M, Ozturk O, et al. A case of oculoglandular tularemia resistant to medical treatment. Scand J Infect Dis 2013;45:725-7. https://doi.org/10.3109/00365548.2013.796089
  10. Park CH, Nakanishi A, Hatai H, Kojima D, Oyamada T, Sato H, et al. Pathological and microbiological studies of Japanese Hare (Lepus brachyurus angustidens) naturally infected with Francisella tularensis subsp. holarctica. J Vet Med Sci 2009;71:1629-35. https://doi.org/10.1292/jvms.001629
  11. Kizil Y, Aydil U, Cebeci S, Guzeldir OT, Inal E, Bayazit Y. Characteristics and management of intractable neck involvement in tularemia: report of 19 patients. Eur Arch Otorhinolaryngol 2012;269:1285-90. https://doi.org/10.1007/s00405-011-1830-5
  12. Oz F, Eksioglu A, Tanir G, Bayhan G, Metin O, Teke TA. Evaluation of clinical and sonographic features in 55 children with tularemia. Vector Borne Zoonotic Dis 2014;14:571-5. https://doi.org/10.1089/vbz.2013.1517
  13. Penn RL. Francisella tularensis (tularemia). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases, 7th ed. Philadelphia (PA): Elsevier-Churchill Livingstone, 2010:2927-37.
  14. Boisset S, Caspar Y, Sutera V, Maurin M. New therapeutic approaches for treatment of tularaemia: a review. Front Cell Infect Microbiol 2014;4:40.
  15. Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 1994;19:42-7. https://doi.org/10.1093/clinids/19.1.42
  16. Kaya A, Uysal IO, Guven AS, Engin A, Gulturk A, Icagasioglu FD, et al. Treatment failure of gentamicin in pediatric patients with oropharyngeal tularemia. Med Sci Monit 2011;17:CR376-80.
  17. Kreizinger Z, Makrai L, Helyes G, Magyar T, Erdelyi K, Gyuranecz M. Antimicrobial susceptibility of Francisella tularensis subsp. holarctica strains from Hungary, Central Europe. J Antimicrob Chemother 2013; 68:370-3. https://doi.org/10.1093/jac/dks399